Latest News & Features
Europe
As Ukraine lifts the wartime pause on IP deadlines, the country's lawyers are determined to get back to business as usual—in spite of the ongoing missile attacks and power outages, finds Sarah Speight. 7 May 2025
Americas
In just 100 days, the Trump administration has issued a record-breaking 90 executive orders—triggering operational uncertainty, staffing upheaval, and growing delays at the US Patent and Trademark Office, hears Marisa Woutersen at LSPN in Boston. 7 May 2025
Careers
Pinsent Masons’ head of IP moves with a small team that will be bolstered by an A&O Shearman associate. 7 May 2025
Americas
The ‘Wands factors’ are extending patent litigation—allowing functionally defined claims to survive longer than expected, hears Marisa Woutersen in Boston. 6 May 2025
Americas
Decision follows director review ordered by Kathi Vidal two years ago | Two pieces of prior art successfully cited in arguments key to invalidation. 6 May 2025
Americas
The pharma giant and biopharma company Incyte announce settlement of dispute over alleged unpaid royalties | News comes on eve of trial in Manhattan. 6 May 2025
Americas
The team brings experience in Section 337 investigations, post-grant proceedings, and complex patent litigation in biopharmaceutical and medical device sectors. 6 May 2025
Europe
Appeals court overturns lower court ruling in decision establishing key standards for patent interpretation | Global dispute between the two insulin pump makers intensifies amid separate US trade secret litigation. 2 May 2025
Americas
Latest report highlights increasing concerns over counterfeit pharmaceuticals, IP barriers, and market access challenges | Key countries to watch include India, China, the UAE, and Singapore | Report also outlines challenges in Mexico, Russia, Brazil, and Indonesia. 1 May 2025
Americas
Duo behind Comirnaty fails to convince Delaware judge to dismiss Alnylam patent claims on grounds of invalidity. 1 May 2025